Julia Marcus, PhD, MPH is an infectious disease epidemiologist and Assistant Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, and Adjunct Faculty at The Fenway Institute. Her primary research focus is improving the implementation of preexposure prophylaxis (PrEP) to prevent new HIV infections and promote sexual health. Her studies have leveraged data from electronic health records (EHRs) to identify patients who may benefit from PrEP, characterize PrEP uptake and continuation, and document clinical outcomes among PrEP users in real-world healthcare settings. She is also co-leading implementation projects to evaluate whether EHR-based predictive analytics and clinical decision support can improve PrEP prescribing in diverse healthcare settings.
In addition to her research, Dr. Marcus has contributed timely op-eds on current events, including a piece in STAT News on whether a new PrEP pill will fuel progress or profits and one in The Atlantic on harm reduction in the coronavirus pandemic. The Atlantic piece is also available in Spanish here1.
Dr. Marcus received her doctoral degree in epidemiology from the University of California, Berkeley, and completed a postdoctoral fellowship at the Kaiser Permanente Division of Research.
1This article was originally published on the website TheAtlantic.com and is republished here with The Atlantic's permission